ES2104223T3 - 2-((2-(n-isobutil-n-metil)amino)-bencilsulfinil)bencimidazol como agente antimicrobiano contra helicobacter pylori. - Google Patents

2-((2-(n-isobutil-n-metil)amino)-bencilsulfinil)bencimidazol como agente antimicrobiano contra helicobacter pylori.

Info

Publication number
ES2104223T3
ES2104223T3 ES94105859T ES94105859T ES2104223T3 ES 2104223 T3 ES2104223 T3 ES 2104223T3 ES 94105859 T ES94105859 T ES 94105859T ES 94105859 T ES94105859 T ES 94105859T ES 2104223 T3 ES2104223 T3 ES 2104223T3
Authority
ES
Spain
Prior art keywords
benzmidazole
isobutyl
amino
methyl
bencilsulfinil
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94105859T
Other languages
English (en)
Inventor
Mitsuo Masaki
Tomio Yamakawa
Yutaka Nomura
Hitoshi Matsukura
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nippon Chemiphar Co Ltd
Original Assignee
Nippon Chemiphar Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Chemiphar Co Ltd filed Critical Nippon Chemiphar Co Ltd
Application granted granted Critical
Publication of ES2104223T3 publication Critical patent/ES2104223T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles

Abstract

EL 2[[2-(N-ISOBUTIL-N-METIL)AMINO]-BENCILSULFINILO]BENCIMIDAZOL ES EFECTIVO EN EL TRATAMIENTO O PREVENCION DE INFECCIONES DE HELICOBACTER MEDIANTE ADMINISTRACION A PACIENTES QUE SUFREN SU INFECCION.
ES94105859T 1993-04-16 1994-04-15 2-((2-(n-isobutil-n-metil)amino)-bencilsulfinil)bencimidazol como agente antimicrobiano contra helicobacter pylori. Expired - Lifetime ES2104223T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP5113942A JPH06298611A (ja) 1993-04-16 1993-04-16 抗菌剤

Publications (1)

Publication Number Publication Date
ES2104223T3 true ES2104223T3 (es) 1997-10-01

Family

ID=14625066

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94105859T Expired - Lifetime ES2104223T3 (es) 1993-04-16 1994-04-15 2-((2-(n-isobutil-n-metil)amino)-bencilsulfinil)bencimidazol como agente antimicrobiano contra helicobacter pylori.

Country Status (5)

Country Link
US (1) US5576341A (es)
EP (1) EP0621035B1 (es)
JP (1) JPH06298611A (es)
DE (1) DE69404200T2 (es)
ES (1) ES2104223T3 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9904044D0 (sv) * 1999-11-09 1999-11-09 Astra Ab Compounds
AU2002322720B2 (en) 2001-07-25 2008-11-13 Raptor Pharmaceutical Inc. Compositions and methods for modulating blood-brain barrier transport
JP3958748B2 (ja) * 2004-02-20 2007-08-15 株式会社日本生物科学研究所 抗菌剤
EP2392258B1 (en) 2005-04-28 2014-10-08 Proteus Digital Health, Inc. Pharma-informatics system
MX2009002893A (es) 2006-09-18 2009-07-10 Raptor Pharmaceutical Inc Tratamiento de trastornos hepaticos mediante la administracion de conjugados de la proteina asociada al receptor (rap).
TR201908314T4 (tr) 2009-02-20 2019-06-21 2 Bbb Medicines B V Glutatyon bazlı ilaç dağıtım sistemi.
IL295075A (en) 2009-05-06 2022-09-01 Laboratory Skin Care Inc Preparations for administration through the skin that include complexes of an active substance with calcium phosphate and methods of using them
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4640985A (en) * 1984-08-31 1986-03-06 Nippon Chemiphar Co. Ltd. Benzimidazole derivatives
DE3887353T2 (de) * 1987-10-12 1994-05-05 Exomed Australia Pty Ltd Behandlungsverfahren für magen-darm-krankheiten.
DK0382489T3 (da) * 1989-02-10 1995-01-16 Takeda Chemical Industries Ltd Monoklonalt anti-humant papillomvirusantistof, hybridomcelle, der producerer dette, samt fremgangsmåde til fremstilling deraf
JPH03161440A (ja) * 1989-11-17 1991-07-11 Yoshitomi Pharmaceut Ind Ltd 抗菌剤

Also Published As

Publication number Publication date
US5576341A (en) 1996-11-19
DE69404200T2 (de) 1998-01-08
EP0621035B1 (en) 1997-07-16
EP0621035A1 (en) 1994-10-26
DE69404200D1 (de) 1997-08-21
JPH06298611A (ja) 1994-10-25

Similar Documents

Publication Publication Date Title
AU8335291A (en) Drugs, their manufacture, and their use as painkillers and/or to treat inflammations in humans and animals
CO4970691A1 (es) Terapia en combinacion para erradicar vhc-arn detectable en pacientes que padecen infeccion de hepatitis c cronica
KR950002785A (ko) 골량을 증가시키기 위한 부갑상선 호르몬 및 랄옥시펜
FI19991893A (fi) Säädellysti budesonidia vapauttava oraalisesti annettava koostumus ja budesonidin käyttö
PT880350E (pt) Tratamento de esclerose multipla
PL310474A1 (en) Application of rilusole in treating neuro-aids diseases
BR0013010A (pt) Formulação de cloreto de sódio de moxifloxacina
ES2071322T3 (es) Reduccion o prevencion de la irritacion de la piel por farmacos.
BR9916114A (pt) Uso de apomorfina na fabricação de um medicamento para tratamento de disfunção erétil orgânica masculina
ES2087623T3 (es) Derivados de bencimidazol como agente antimicrobiano contra campylobacter pylon.
ES2104223T3 (es) 2-((2-(n-isobutil-n-metil)amino)-bencilsulfinil)bencimidazol como agente antimicrobiano contra helicobacter pylori.
HK1037980A1 (en) Use of selegiline or desmethylselegiline for the manufacture of a medicament for treating wounds, burns or photodamage.
ES2136167T3 (es) Composiciones de idebenona para tratar la enfermedad de alzheimer.
SE9601395D0 (sv) New therapeutic treatment 1
EP0744176A3 (en) Methods for inhibiting bone loss
BR0115215A (pt) Método para o tratamento de inflamações
EP1073436A4 (en) IMPROVED METHOD FOR ERADICATION OF HELICOBACTER PYLORI
ATE83657T1 (de) Pharmazeutische zusammensetzung.
KR970704442A (ko) 일시적인 병소 허혈에 의해 유발된 재관류 손상을 치료하기 위한 (S)-아데노실-L-메티오닌(SAMe) 및 그의 생리학상 적합한 염의 용도(Use of (S)-Adenosy-L-Methionine(SAMe) and lts Physiologically Compatible Salts for Treating Reperfusion Damage Triggered by Temporary Focal lschaemia)
MD196C2 (ro) Izonicotinoilhidrazonă a aldehidei 5-nitro-2-furanice
ES2170377T3 (es) Composicion que contiene quitosana.
ES2101311T3 (es) Utilizacion de un dispositivo transdermico que contiene (e)-2-(p-fluorofenetil)-3-fluoroalilamina y su uso para el tratamiento de la enfermedad de alzheimer.
WO1999065511A3 (en) Composition and method for treatment of pseudomonas infection
CO5031290A1 (es) Formulacion lo
EP1143981A4 (en) TREATMENT AND PREVENTION OF HIV AND OTHER VIRUS INFECTIONS

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 621035

Country of ref document: ES